Morepen Laboratories Limited NSE Symbol:MOREPENLAB, BSE Security Code:500288 has declared its 3rd(third) quarter un-audited Consolidated financial report from the month of October, 2019 to the month of December, 2019; for the fiscal year 2019-20.
Revenue Reported by Morepen Laboratories Limited for Third Quarter FY, 2019-20 | ||||
Current Quarter (October, 2019 - December, 2019) | Previous Quarter (July, 2019 - September, 2019) | Corresponding Quarter (October, 2018 - December, 2018) | 9 Months Ended (April, 2019 - December, 2019) | Corresponding 9 Months Ended (April, 2018 - December, 2018) |
234.66 | 216.24 | 214.59 | 654.16 | 552.47 |
Calculated Revenue of Morepen Laboratories Limited for Third Quarter FY, 2019-20 | |||||
Current(December, 2019) VS Previous(September, 2019) | Current(December, 2019) VS Corresponding(December, 2018) | 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018) | |||
Change | Change % | Change | Change % | Change | Change % |
18.42 | 8.52%(Revenue Increase) | 20.07 | 9.35%(Revenue Increase) | 101.69 | 18.41%(Revenue Increase) |
Revenue: Morepen Laboratories Limited's financial report shows that the company's revenue increased by 8.52% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for revenue increase of Rs.18.42 crores, as the company posted revenue of Rs.234.66 crores; in compare to previous quarter(July, 2019 - September, 2019) when the company reported revenue of Rs.216.24 crores.
The result also shows that the company's revenue increased by 9.35% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for revenue increase of Rs.20.07 crores; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted revenue of Rs.214.59 crores.
The company also reported that its revenue increased by 18.41% in 9 months end(April, 2019 - December, 2019) for revenue increase of Rs.101.69 crores, since the company reported revenue of Rs.654.16 crores; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted revenue of Rs.552.47 crores.
Gross Margin(%) Reported by Morepen Laboratories Limited for Third Quarter FY, 2019-20 | ||||
Current Quarter (October, 2019 - December, 2019) | Previous Quarter (July, 2019 - September, 2019) | Corresponding Quarter (October, 2018 - December, 2018) | 9 Months Ended (April, 2019 - December, 2019) | Corresponding 9 Months Ended (April, 2018 - December, 2018) |
13.60 | 25.28 | 23.85 | 23.72 | 30.00 |
Calculated Gross Margin(%) of Morepen Laboratories Limited for Third Quarter FY, 2019-20 | |||||
Current(December, 2019) VS Previous(September, 2019) | Current(December, 2019) VS Corresponding(December, 2018) | 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018) | |||
Change | Change % | Change | Change % | Change | Change % |
11.68 | 46.20%(GM Decrease) | 10.25 | 42.98%(GM Decrease) | 6.28 | 20.93%(GM Decrease) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 46.20% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for 11.68% GM decrease, as the company reported 13.60% GM; in compare to previous quarter(July, 2019 - September, 2019) when the company reported 25.28% GM.
The result also indicates, the company's GM decreased by 42.98% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for 10.25% GM decrease; in compare to corresponding quarter(October, 2018 - December, 2018) when the company reported 23.85% GM.
The company also reported that its GM decreased by 20.93% in 9 months end(April, 2019 - December, 2019) for 6.28% GM decrease, since the company reported 23.72% GM; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company reported 30.00% GM.
EBITDA Reported by Morepen Laboratories Limited for Third Quarter FY, 2019-20 | ||||
Current Quarter (October, 2019 - December, 2019) | Previous Quarter (July, 2019 - September, 2019) | Corresponding Quarter (October, 2018 - December, 2018) | 9 Months Ended (April, 2019 - December, 2019) | Corresponding 9 Months Ended (April, 2018 - December, 2018) |
19.89 | 7.55 | 19.27 | 47.01 | 48.42 |
Calculated EBITDA of Morepen Laboratories Limited for Third Quarter FY, 2019-20 | |||||
Current(December, 2019) VS Previous(September, 2019) | Current(December, 2019) VS Corresponding(December, 2018) | 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018) | |||
Change | Change % | Change | Change % | Change | Change % |
12.34 | 163.44%(EBITDA Increase) | 0.62 | 3.22%(EBITDA Increase) | 1.41 | 2.91%(EBITDA Decrease) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 163.44% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EBITDA increase of Rs.12.34 crores, as the company posted EBITDA of Rs.19.89 crores; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EBITDA of Rs.7.55 crores.
The result also shows that the company's EBITDA increased by 3.22% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EBITDA increase of Rs.0.62 crore; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted EBITDA of Rs.19.27 crores.
The company also reported that its EBITDA decreased by 2.91% in 9 months end(April, 2019 - December, 2019) for EBITDA decrease of Rs.1.41 crores, since the company reported EBITDA of Rs.47.01 crores; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted EBITDA of Rs.48.42 crores.
Profit and Loss Reported by Morepen Laboratories Limited for Third Quarter FY, 2019-20 | ||||
Current Quarter (October, 2019 - December, 2019) | Previous Quarter (July, 2019 - September, 2019) | Corresponding Quarter (October, 2018 - December, 2018) | 9 Months Ended (April, 2019 - December, 2019) | Corresponding 9 Months Ended (April, 2018 - December, 2018) |
10.82(Profit ) | 4.08(Profit ) | 8.91(Profit ) | 22.56(Profit ) | 18.35(Profit ) |
Calculated Profit and Loss of Morepen Laboratories Limited for Third Quarter FY, 2019-20 | |||||
Current(December, 2019) VS Previous(September, 2019) | Current(December, 2019) VS Corresponding(December, 2018) | 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018) | |||
Change | Change % | Change | Change % | Change | Change % |
6.74 | 165.20%(Profit Increase) | 1.91 | 21.44%(Profit Increase) | 4.21 | 22.94%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 165.20% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for profit increase of Rs.6.74 crores, as the company posted profit of Rs.10.82 crores; in compare to previous quarter(July, 2019 - September, 2019) when the company reported profit of Rs.4.08 crores.
The result also shows that the company's profit increased by 21.44% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for profit increase of Rs.1.91 crores; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted profit of Rs.8.91 crores.
The company also reported that its profit increased by 22.94% in 9 months end(April, 2019 - December, 2019) for profit increase of Rs.4.21 crores, since the company reported profit of Rs.22.56 crores; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted profit of Rs.18.35 crores.
EPS Reported by Morepen Laboratories Limited for Third Quarter FY, 2019-20 | ||||
Current Quarter (October, 2019 - December, 2019) | Previous Quarter (July, 2019 - September, 2019) | Corresponding Quarter (October, 2018 - December, 2018) | 9 Months Ended (April, 2019 - December, 2019) | Corresponding 9 Months Ended (April, 2018 - December, 2018) |
0.24 | 0.09 | 0.20 | 0.50 | 0.41 |
Calculated EPS of Morepen Laboratories Limited for Third Quarter FY, 2019-20 | |||||
Current(December, 2019) VS Previous(September, 2019) | Current(December, 2019) VS Corresponding(December, 2018) | 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018) | |||
Change | Change % | Change | Change % | Change | Change % |
0.15 | 166.67%(EPS Increase) | 0.04 | 20.00%(EPS Increase) | 0.09 | 21.95%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 166.67% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EPS increase of Rs.0.15, as the company posted EPS of Rs.0.24; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EPS of Rs.0.09.
The result also shows that the company's EPS increased by 20.00% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EPS increase of Rs.0.04; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted EPS of Rs.0.20.
The company also reported that its EPS increased by 21.95% in 9 months end(April, 2019 - December, 2019) for EPS increase of Rs.0.09, since the company reported EPS of Rs.0.50; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted EPS of Rs.0.41.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Comments